Sophia Genetics (Sophia Genetics) Ending Cash Position : $103.74 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics Ending Cash Position?

Sophia Genetics's Ending Cash Position for the quarter that ended in Mar. 2024 was $103.74 Mil.

Sophia Genetics's quarterly Ending Cash Position declined from Sep. 2023 ($132.77 Mil) to Dec. 2023 ($123.25 Mil) and declined from Dec. 2023 ($123.25 Mil) to Mar. 2024 ($103.74 Mil).

Sophia Genetics's annual Ending Cash Position declined from Dec. 2021 ($192.96 Mil) to Dec. 2022 ($161.31 Mil) and declined from Dec. 2022 ($161.31 Mil) to Dec. 2023 ($123.25 Mil).

Sophia Genetics Ending Cash Position Historical Data

The historical data trend for Sophia Genetics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics Ending Cash Position Chart

Sophia Genetics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

18.07

74.63

192.96

161.31

123.25

Sophia Genetics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial													160.76	148.55	132.77	123.25	103.74

Sophia Genetics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sophia Genetics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	161.305	+	-38.054
	=	123.25

Sophia Genetics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	123.251	+	-19.516
	=	103.74

Sophia Genetics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sophia Genetics (Sophia Genetics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

90B:Germany

Address

Rue du Centre 172, Saint-Sulpice, CHE, CH-1025

Website

https://www.sophiagenetics.com

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.